These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

783 related articles for article (PubMed ID: 18622246)

  • 1. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency.
    Eräranta A; Kurra V; Tahvanainen AM; Vehmas TI; Kööbi P; Lakkisto P; Tikkanen I; Niemelä OJ; Mustonen JT; Pörsti IH
    J Hypertens; 2008 Aug; 26(8):1661-8. PubMed ID: 18622246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
    Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
    J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oxonic acid-induced hyperuricemia on mesenteric artery tone and cardiac load in experimental renal insufficiency.
    Kurra V; Vehmas T; Eräranta A; Jokihaara J; Pirttiniemi P; Ruskoaho H; Tokola H; Niemelä O; Mustonen J; Pörsti I
    BMC Nephrol; 2015 Mar; 16():35. PubMed ID: 25886588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.
    Mazzali M; Kanellis J; Han L; Feng L; Xia YY; Chen Q; Kang DH; Gordon KL; Watanabe S; Nakagawa T; Lan HY; Johnson RJ
    Am J Physiol Renal Physiol; 2002 Jun; 282(6):F991-7. PubMed ID: 11997315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperuricemia, oxidative stress, and carotid artery tone in experimental renal insufficiency.
    Kurra V; Eräranta A; Jolma P; Vehmas TI; Riutta A; Moilanen E; Tahvanainen A; Kalliovalkama J; Niemelä O; Myllymäki J; Mustonen J; Pörsti I
    Am J Hypertens; 2009 Sep; 22(9):964-70. PubMed ID: 19521342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild hyperuricemia induces glomerular hypertension in normal rats.
    Sánchez-Lozada LG; Tapia E; Avila-Casado C; Soto V; Franco M; Santamaría J; Nakagawa T; Rodríguez-Iturbe B; Johnson RJ; Herrera-Acosta J
    Am J Physiol Renal Physiol; 2002 Nov; 283(5):F1105-10. PubMed ID: 12372787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local angiotensin formation in hindlimbs of uremic hypertensive and renovascular hypertensive rats.
    Kuczera M; Hilgers KF; Lisson C; Ganten D; Hilgenfeldt U; Ritz E; Mann JF
    J Hypertens; 1991 Jan; 9(1):41-8. PubMed ID: 1848258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma renin-angiotensin system or protein intake.
    Horike K; Usami T; Kamiya Y; Kamiya T; Yoshida A; Itoh S; Yamato H; Ise M; Kimura G
    Clin Exp Nephrol; 2003 Jun; 7(2):120-4. PubMed ID: 14586730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia.
    Sánchez-Lozada LG; Tapia E; Soto V; Avila-Casado C; Franco M; Zhao L; Johnson RJ
    Nephrol Dial Transplant; 2008 Apr; 23(4):1179-85. PubMed ID: 18048425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
    Vaziri ND; Bai Y; Ni Z; Quiroz Y; Pandian R; Rodriguez-Iturbe B
    J Pharmacol Exp Ther; 2007 Oct; 323(1):85-93. PubMed ID: 17636006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in aldosterone and angiotensin II levels in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Emmett N; Socci RR; Eatman D; Fridie IL
    Clin Exp Hypertens; 2005 May; 27(4):355-67. PubMed ID: 15921072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric acid: bystander or culprit in hypertension and progressive renal disease?
    Menè P; Punzo G
    J Hypertens; 2008 Nov; 26(11):2085-92. PubMed ID: 18854744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased aldosterone levels in a model of type 2 diabetes mellitus.
    Fredersdorf S; Endemann DH; Luchner A; Heitzmann D; Ulucan C; Birner C; Schmid P; Stoelcker B; Resch M; Muders F; Riegger GA; Weil J
    Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):15-20. PubMed ID: 18726873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary phosphate binding and loading alter kidney angiotensin-converting enzyme mRNA and protein content in 5/6 nephrectomized rats.
    Eräranta A; Riutta A; Fan M; Koskela J; Tikkanen I; Lakkisto P; Niemelä O; Parkkinen J; Mustonen J; Pörsti I
    Am J Nephrol; 2012; 35(5):401-8. PubMed ID: 22517117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys.
    Chandramohan G; Bai Y; Norris K; Rodriguez-Iturbe B; Vaziri ND
    Am J Nephrol; 2008; 28(1):158-67. PubMed ID: 17951998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular Angiotensin type 1 receptor expression is associated with vascular dysfunction, oxidative stress and inflammation in fructose-fed rats.
    Nyby MD; Abedi K; Smutko V; Eslami P; Tuck ML
    Hypertens Res; 2007 May; 30(5):451-7. PubMed ID: 17587757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease.
    Bovée DM; Uijl E; Severs D; Rubio-Beltrán E; van Veghel R; Maassen van den Brink A; Joles JA; Zietse R; Cuevas CA; Danser AHJ; Hoorn EJ
    Am J Physiol Renal Physiol; 2021 Apr; 320(4):F654-F668. PubMed ID: 33586496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AT1 receptor and ACE mRNA are increased in chemically induced carcinoma of rat mammary gland.
    Tybitanclova K; Macejova D; Liska J; Brtko J; Zorad S
    Mol Cell Endocrinol; 2005 Dec; 244(1-2):42-6. PubMed ID: 16225983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.
    Mizobuchi M; Morrissey J; Finch JL; Martin DR; Liapis H; Akizawa T; Slatopolsky E
    J Am Soc Nephrol; 2007 Jun; 18(6):1796-806. PubMed ID: 17513326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.